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Summary.Background: Apparent comorbidity between bipolar disorder (BD) and obsessive-compulsive dis-
order (OCD) is a common condition in psychiatry and it has important nosological and therapeutic implica-
tions. Although antidepressants are the first line treatment for OCD, they can induce mood instability in BD. 
An optimal treatment approach remains to be defined. Methods: Longitudinal clinical observation of three 
severe OCD patients who developed a manic episode during treatment with different classes of antidepres-
sants. Results: In our cases, three features support the hypothesis of an underlying bipolarity unmasked by 
the antidepressant used to treat OCD: positive family history for affective disorders, manic switch induced 
by antidepressant and improvement of affective and obsessive-compulsive symptoms with mood stabilizers 
and atypical antipsychotics. Conclusions: Osler’s view that medicine should be treatment of diseases, not of 
symptoms, is consistent with the approach of mood stabilization as a first objective in BD-OCD patients, as 
opposed to immediate treatment with antidepressants. Only persistent OCD patients should be prescribed 
antidepressants in as low a dose as feasible. (www.actabiomedica.it)
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C a s e  r e p o r t
Introduction
Apparent comorbidity between bipolar disorder 
(BD) and obsessive-compulsive disorder (OCD) is a 
common condition in psychiatry with higher preva-
lence rates in youths compared to adults (1). The mean-
ing of this comorbidity has not been clarified yet (2).
In a standard 1969 psychiatry textbook, Mayer-
Gross and colleagues included patients with BD-OCD 
comorbidity in the manic-depressive disorders (3). 
Considering course of illness as a key diagnostic valida-
tor (4), the evidence so far on BD-OCD nosology sup-
ports the view that the majority of comorbid OCD 
cases appeared to be related to mood episodes (5).
However, an optimal BD-OCD treatment ap-
proach remains to be defined since the gold stan-
dard for one disease (6) – according to the American 
Psychiatric Association – can worsen the other (7). 
Several published case reports describe OCD patients 
who developed manic episodes induced by different 
serotonin reuptake inhibitors (SRIs) (8): this raises the 
question of comorbidity between BD and OCD.
We present a longitudinal clinical observation of 
three severe OCD patients who developed a manic 




The patient is a 56 year-old Caucasian unmarried 
woman with positive family history for major depres-
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sive disorder. From the age of 20, she had presented 
fear of contamination, leading to elaborate washing 
and cleaning rituals that had partially impaired her 
functional capacity. These symptoms met DSM-IV 
(Diagnostic and Statistical Manual of Mental Disor-
ders, 4th Edition) criteria for OCD and were untreated 
for 34 years. No history of manic or depressive epi-
sodes was reported.
At the age of 54, a few months after leaving her 
parents’ home, the obsessions and compulsions in-
creased and she presented with depressed mood and 
feelings of worthlessness. She was admitted to the in-
patient service and treated with sertraline 200 mg/day; 
obsessive-compulsive and affective symptoms were 
well controlled and satisfactory quality of life was re-
gained.
After eight months on sertraline 250 mg/day, she 
developed a manic episode. Her therapy was modified 
to valproate 1000 mg/day and olanzapine 10 mg/day. 
Olanzapine was gradually decreased and valproate was 
continued for the next five months with remission of 
obsessive-compulsive symptoms and mood stabiliza-
tion.
After her father’s death, compulsive rituals in-
creased prominently. Sertraline 75 mg/day was added 
to valproate and again complete remission of bipolar 
and obsessive-compulsive symptoms for the following 
months was reported.
Case 2
The patient is a 32 year-old Caucasian man with 
positive family history for recurrent depression. From 
the age of 21, he had presented recurrent, intrusive, 
ego-dystonic thoughts having sexual and aggressive 
content that led him to compulsive mental acts (specif-
ically, praying). These symptoms met DSM-IV criteria 
for OCD. No history of manic or depressive episodes 
was reported.
He was admitted to the inpatient service and 
treated with citalopram 60 mg/day with satisfactory 
control of obsessive-compulsive symptoms.
After three months on citalopram 60 mg/day, he 
developed a manic episode. His therapy was modi-
fied to valproate 800 mg/day and olanzapine 20 mg/
day. Olanzapine was gradually decreased and valproate 
was continued with remission of obsessive-compulsive 
symptoms and mood stabilization.
After eight months he decided to stop valproate 
and compulsive rituals increased prominently. Citalo-
pram 20mg/day was added to valproate with improve-
ment of OC symptoms and mood stabilization.
Case 3
The patient is a 24 year-old Caucasian woman 
with positive family history for recurrent depression. 
At 19 years of age, two weeks after delivery, she pre-
sented a major depressive episode that improved in the 
next few weeks with fluvoxamine 100 mg/day.
From the age of 22, she had gradually presented 
fear of contamination with hand washing more than 
ten times per day, pathological doubts about daily 
events, and compulsive checking of light switches. 
These symptoms met DSM-IV criteria for OCD. No 
history of manic episodes was reported.
She was admitted to the inpatient service and in-
itially treated with fluvoxamine 200 mg/day without 
satisfactory control of obsessive-compulsive symptoms. 
Her therapy was modified to clomipramine 150 mg/day. 
After four weeks she developed a manic episode. 
Her therapy was modified to lithium 900 mg/day 
and aripiprazole 30 mg/day. Aripiprazole was grad-
ually decreased and lithium was continued with mood 
stabilization and remission of obsessive-compulsive 
symptoms.
After three months washing and checking rituals 
increased prominently. Aripiprazole 10 mg/day was 
added to lithium and affective and obsessive-compul-
sive symptoms were well controlled for the following 
twelve months.
Discussion
In our cases, three features support the hypoth-
esis of an underlying bipolarity unmasked by the anti-
depressant used to treat OCD: positive family history 
for affective disorders (9), manic switch induced by 
antidepressant (7) and improvement of affective and 
obsessive-compulsive symptoms with mood stabilizers 
and atypical antipsychotics (10).
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The co-occurrence of symptoms of BD and OCD 
was noted 150 years ago by Morel (11), but the topic 
remains insufficiently studied. However, given the 
available scientific evidence, some observations can be 
made.
Apparent BD-OCD comorbidity is a common 
condition in psychiatry with higher prevalence rates in 
youths compared to adults (12). In particular, as re-
ported by recent studies, obsessive-compulsive symp-
toms in childhood and adolescence increase the risk 
of a later BD diagnosis (13). Considering course of 
illness as a key diagnostic validator, especially among 
patients with a primary diagnosis of BD, the major-
ity of comorbid OCD cases appeared to be related 
to mood episodes (4). Obsessive-compulsive symp-
toms in comorbid patients appeared more often - and 
sometimes exclusively - during depressive episodes, 
and comorbid BD and OCD cycled together, with 
obsessive-compulsive symptoms often remitting dur-
ing manic/hypomanic episodes. The clinical features 
of comorbid BD-OCD patients would explain why 
OCD and BD symptoms respond to adequate mood 
stabilizers and atypical antipsychotics (10). Only in a 
minority of comorbid patients with persistent OCD, 
despite improvement in mood episodes, addition of 
low doses of antidepressants could be considered while 
strictly monitoring emerging symptoms of mania or 
mixed states.  
Progress in this area would serve to shed light on 
the best clinical management of BD-OCD comorbid-
ity. Considering the important nosological, clinical and 
therapeutic implications, future research efforts may 
lead to more grounded guidelines, which are greatly 
needed in patients with comorbid BD-OCD.
Clinical implications
Osler’s view that medicine should be treatment of 
diseases, not of symptoms (14), is consistent with the 
approach of mood stabilization as the primary goal in 
treating apparent BD-OCD patients, as opposed to 
immediate treatment with antidepressants that seemed 
to be less effective and more harmful in BD-OCD 
than in non-comorbid patients.
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